Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In resource-limited settings, early mortality on antiretroviral therapy (ART) is approximately 10%; yet, it is unclear how much of that mortality occurs in care or after lost to follow-up. We assessed mortality rates and predictors of death among 12,222 nonpregnant ART-naive adults initiating first-line ART between April 2004 and May 2012 in South Africa, stratified by person-years in care and lost. We found 14.6% of patients died and being lost accounted for a minority of deaths across multiple definitions of loss (population attributable-risk percent ranged from 10.4% to 42.5%). Although mortality rates in patients lost were much higher than in care, most ART-related mortality occurred on treatment.

Original publication

DOI

10.1097/QAI.0000000000000755

Type

Journal article

Journal

J Acquir Immune Defic Syndr

Publication Date

01/11/2015

Volume

70

Pages

323 - 328

Keywords

Adolescent, Adult, Ambulatory Care, Anti-HIV Agents, CD4 Lymphocyte Count, Female, HIV Infections, Humans, Lost to Follow-Up, Male, Middle Aged, South Africa, Young Adult